Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$17.71 USD
+0.38 (2.19%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $17.70 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.71 USD
+0.38 (2.19%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $17.70 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Zacks News
Quest Diagnostics Buys 2 Outreach Labs, Widens Customer Base
by Zacks Equity Research
Quest Diagnostics (DGX) completes acquisition of outreach laboratory services of two Hartford HealthCare hospitals. The deal is expected to widen the network of the company.
Abbott Gets FDA Nod for FreeStyle Libre, Boosts Diabetes Arm
by Zacks Equity Research
Abbott's (ABT) diabetes care segment to strengthen with the FDA approval for FreeStyle Libre Flash glucose monitoring system.
Edwards Lifesciences Pipeline Impressive, Currency Woes Stay
by Zacks Equity Research
Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.
Quest Diagnostics to Buy Shiel to Widen Footprint in NY-NJ
by Zacks Equity Research
After the completion of Shiel's acquisition, the medical lab is expected to expand Quest Diagnostics' (DGX) physician and patient service centers network in the New York-New Jersey area.
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
by Zacks Equity Research
Stryker Corporation (SYK) has successfully expanded its product portfolio over time, which aids the company to cater to evolving demands of customers.
Here's Why You Should Invest in Orthofix International Now
by Zacks Equity Research
Orthofix (OFIX) rides high on strength in Biologics and Spine Fixation.
New Strong Buy Stocks for September 22nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Quidel Corporation (QDEL) Jumps: Stock Rises 6.5%
by Zacks Equity Research
Quidel Corporation (QDEL) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Orthofix (OFIX) is a Great Momentum Pick for You: Here's Why
by Zacks Equity Research
Banking on a number of favorable metrics, Orthofix (OFIX) stands out as one of the most suitable momentum stock.
Anika (ANIK) Grows in Orthopedic Medicines on Positive Data
by Zacks Equity Research
Anika Therapeutics' (ANIK) data shows HYALOFAST as an effective treatment option for cartilage lesions, suitable to all age groups.
Orthofix (OFIX) Earnings Meet, Sales Beat Estimates in Q2
by Zacks Equity Research
Orthofix (OFIX) rides high on strength in Biologics and Spine Fixation businesses. Moreover, raised full-year 2017 guidance buoys optimism.
Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards Lifesciences, Orthofix International and INSYS Therapeutics
MedTech Industry Outlook - July 2017
by Zacks Equity Research
The overall expectation is that President Trump's legislative change for MedTech will result in lower taxes and regulation for the industry as a whole.
MedTech Industry Outlook - March 2017
by Zacks Equity Research
A shrinking customer base indicates an impending slash in the demand for expensive medical procedures and devices.
Orthofix International (OFIX) Looks Good: Stock Jumps 9.9%
by Zacks Equity Research
Orthofix International N.V. (OFIX) moved big last session, as its shares jumped almost 10% on the day.